Researchers at Tel Aviv University (TAU) have successfully used CRISPR gene-editing technology to remove a single gene from cancer cells in head and neck tumors, resulting in the elimination of 50% of the tumors in animal models. The study, led by Dr. Razan Masarwy and Prof. Dan Peer, was published in the journal Advanced Science. The researchers used specialized lipid particles to deliver the CRISPR system in RNA format, targeting a protein receptor known as EGF found on cancer cells. This approach could potentially be effective against many types of cancer cells.